Need for Extensive Cancer Research:
For many decades, cancer has imposed massive health and economic burden worldwide. Despite numerous advances in modern medicine, the current era observes an increase in the human and economic toll of various cancers such as lung cancer, breast cancer, colorectal cancer, blood cancer, and so on. Extensive cancer research is required to foster the development of novel strategies for the prevention, diagnosis, treatment, and cure of tissue cancer and neoplasm cancer. Therefore, abundant knowledge of the biological process of cancer formation, onset, progression, mechanism of metastasis is paramount for a breakthrough in oncology human biorepositories play a pivotal role in oncology research by providing well-annotated, highly characterized, well-preserved cancer tissue samples and blood-derived specimens to standardise cancer research. Furthermore, discovering a permanent cure for cancer entails a global collaborative effort of technological, therapeutic, epidemiological, and ethical research pioneers and scientists.
- Benign tumours: These are noncancerous, insidious localized new growth causing less harm to the host. As it is a localized condition, surgical excision can remove benign tumours.
- Malignant tumours: These are rapidly proliferating tumours that can spread to other body parts (metastasis) and may eventually cause host demise. Malignant tumours are commonly known as cancer.
An Insight to Cancer Samples We Offer:
Central BioHub is a science-driven enterprise that expedites cancer disease esearch and precision human medicine by offering unprecedented access to a multitude of genetically diverse cancer human biospecimens and cancer tissue samples for research. We are a group of dedicated young scientists who have devised a comprehensive strategy for improving the cancer specimen and biopsy specimen acquisition process by bridging between certified international biospecimen suppliers and life science researchers worldwide. Our innovative online marketplace offers the most extensive inventory of cancer samples carefully collected from cancer patients of every age, gender, and ethnicity with full compliance. Every cancer research sample is hyper-annotated with detailed clinical information like diagnosis, concurrent illness, staging, and anticancer therapy undertaken and are available in two matrices:
- Blood biospecimens: It includes serum and plasma samples collected from cancer patients in different stages; conscientiously measured for cancer-antigen 19-9 (CA 19-9), cancer-antigen 125 (CA 125), carcinoembryonic antigen (CEA), and prostate-specific antigen (PSA). Every sample is preserved cryogenically at <-18°C at our supplier’s biorepositories with utmost precision.
- Tumour tissue biospecimens: It includes fresh frozen Cancer tissue samples and FFPE tissue blocks obtained from cancer patients through biopsy or surgical resection. The tumour tissue samples and cells cancer are tested for genetic mutations like HER-2 receptor, estrogen receptor, and progesterone receptor are hyper-annotated with tissue characteristics and clinical information. For example: breast biopsy tissue samples
Central BioHub is a global leader and the world's largest provider of biospecimen . Oncology researchers can purchase cancer biospecimens using Central BioHub's safe, open-access, and rapid virtual interface, with complete support from our scientific customer advisory team. Each cancer human biospecimen is investigated systematically and handled professionally to guarantee research output fidelity. Central BioHub utilises our pursuit of excellence to assure safe and fast international shipping. Contact us to find the most credible, premium quality oncology biospecimens online.